FRANK MCCORMICK
CIK 1257809 · Chairman of Oncology · last filed 2025-10-31
FRANK MCCORMICK is a Chairman of Oncology who has filed 30 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider sold $13.2M of BBIO on Oct 31, 2025. Across all open-market trades the lifetime net is −$33.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $57.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$57.41M
5
30
-$33.91M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BBIO | Director | 818,742 | $66.80 | $54.69M | -$33.91M | 15 | 2025-10-31 |
| BBOT | Director | — | $7.75 | — | $0 | 1 | 2025-08-28 |
| OLMA | Director | 275,373 | $9.87 | $2.72M | $0 | 2 | 2020-11-23 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Director | — | — | — | $0 | 4 | 2018-06-08 |
| EXEL | Director | — | $53.13 | — | $0 | 8 | 2013-12-09 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-10-31 | BBIO | Sell (S) | −198,359 | -$13.21M | EDGAR |
| 2025-10-29 | BBIO | Sell (S) | −1,641 | -$106.7K | EDGAR |
| 2025-09-08 | BBIO | Mixed | — | -$3.05M | EDGAR |
| 2025-08-28 | BBOT | Grant (A) | — | $0 | EDGAR |
| 2025-06-26 | BBIO | Sell (S) | −100,000 | -$4.42M | EDGAR |
| 2025-06-24 | BBIO | Grant (A) | +6,589 | $0 | EDGAR |
| 2025-05-09 | BBIO | Gift (G) | −36,000 | $0 | EDGAR |
| 2025-01-08 | BBIO | Gift (G) | −7,400 | $0 | EDGAR |
| 2024-12-27 | BBIO | Gift (G) | −7,400 | $0 | EDGAR |
| 2024-06-25 | BBIO | Grant (A) | — | $0 | EDGAR |